Authors: BUCKINGHAM RE ALBARAZANJI KA TOSELAND CDN SLAUGHTER M CONNOR SC WEST A BOND B TURNER NC CLAPHAM JC

Citation: Re. Buckingham et al., PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONIST, ROSIGLITAZONE, PROTECTS AGAINST NEPHROPATHY AND PANCREATIC-ISLET ABNORMALITIES INZUCKER FATTY RATS, Diabetes, 47(8), 1998, pp. 1326-1334

Authors: ALBARAZANJI KA BUCKINGHAM RE ARCH JRS HAYNES A MOSSAKOWSKA DE MCBAY DL HOLMES SD MCHALE MT WANG XM GLOGER IS

Citation: Ka. Albarazanji et al., EFFECTS OF INTRACEREBROVENTRICULAR INFUSION OF LEPTIN IN OBESE ZUCKERRATS, Obesity research, 5(5), 1997, pp. 387-394

Authors: ALBARAZANJI KA BALMENT RJ

Citation: Ka. Albarazanji et Rj. Balment, RENAL,ENDOCRINE AND VASCULAR EFFECTS OF ATRIAL-NATRIURETIC-PEPTIDE INA NOVEL VASOPRESSIN-DEFICIENT GENETICALLY HYPERTENSIVE STRAIN OF RAT, Experimental physiology, 80(2), 1995, pp. 275-284

Authors: SMITH SA ALBARAZANJI KA BUCKINGHAM RE CASSIDY F COLDWELL MC FINNEY FJL HADLEY MS HAM P LAWRENCE SA NASH DJ TINGLEY EJR WATSON JM

Citation: Sa. Smith et al., THE IDENTIFICATION OF A NOVEL RENIN INHIBITOR OF EQUIVALENT EFFICACY FOLLOWING ORAL OR INTRAVENOUS ADMINISTRATION, Bioorganic & medicinal chemistry letters, 4(11), 1994, pp. 1291-1296